Oppenheimer analyst Brian Schwartz raised the firm’s price target on Salesforce (CRM) to $385 from $330 and keeps an Outperform rating on the shares. The firm notes the Q3 earnings risk weighs slightly positive for Salesforce based on its research mosaic. The read-through on the Q3 hiring data and Oppenheimer’s earnings preview supports the durability of Salesforce as a good EPS growth compounder, better consistency in the Q3 report, and the outlook appears favorable for Salesforce with a Q4 IT Read More...
Oppenheimer analyst Brian Schwartz raised the firm’s price target on Salesforce (CRM) to $385 from $330 and keeps an Outperform rating on the shares. The firm notes the Q3 earnings risk weighs slightly positive for Salesforce based on its research mosaic. The read-through on the Q3 hiring data and Oppenheimer’s earnings preview supports the durability of Salesforce as a good EPS growth compounder, better consistency in the Q3 report, and the outlook appears favorable for Salesforce with a Q4 IT budget flush likely to happen.
Don’t Miss our Black Friday Offers:
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. >;elm:context_link;itc:0;sec:content-canvas” class=”link”>Try Now>>
Read More on CRM:
Add Comment